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Abstract: OBJECTIVE To define ”best possible” outcomes for bariatric surgery (BS)(Roux-en-Y gastric
bypass [RYGB] and sleeve gastrectomy [SG]). BACKGROUND Reference values for optimal surgical out-
comes in well-defined low-risk bariatric patients have not been established so far. Consequently, outcome
comparison across centers and over time is impeded by heterogeneity in case-mix. METHODS Out of
39,424 elective BS performed in 19 high-volume academic centers from 3 continents between June 2012
and May 2017, we identified 4120 RYGB and 1457 SG low-risk cases defined by absence of previous
abdominal surgery, concomitant procedures, diabetes mellitus, sleep apnea, cardiopathy, renal insuffi-
ciency, inflammatory bowel disease, immunosuppression, anticoagulation, BMI>50 kg/m and age>65
years. We chose clinically relevant endpoints covering the intra- and postoperative course. Complications
were graded by severity using the comprehensive complication index. Benchmark values were defined
as the 75th percentile of the participating centers’ median values for respective quality indicators. RE-
SULTS Patients were mainly females (78%), aged 38±11 years, with a baseline BMI 40.8 ± 5.8 kg/m.
Over 90 days, 7.2% of RYGB and 6.2% of SG patients presented at least 1 complication and no patients
died (mortality in nonbenchmark cases: 0.06%). The most frequent reasons for readmission after 90-
days following both procedures were symptomatic cholelithiasis and abdominal pain of unknown origin.
Benchmark values for both RYGB and SG at 90-days postoperatively were 5.5% Clavien-Dindo grade ฀IIIa
complication rate, 5.5% readmission rate, and comprehensive complication index ฀33.73 in the subgroup
of patients presenting at least 1 grade ฀II complication. CONCLUSION Benchmark cutoffs targeting
perioperative outcomes in BS offer a new tool in surgical quality-metrics and may be implemented in
quality-improvement cycle.ClinicalTrials.gov Identifier NCT03440138.
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Objective: To define ‘‘best possible’’ outcomes for bariatric surgery
(BS)(Roux-en-Y gastric bypass [RYGB] and sleeve gastrectomy [SG]).
Background: Reference values for optimal surgical outcomes in well-
defined low-risk bariatric patients have not been established so far. Conse-
quently, outcome comparison across centers and over time is impeded by
heterogeneity in case-mix.
Methods: Out of 39,424 elective BS performed in 19 high-volume academic
centers from 3 continents between June 2012 and May 2017, we identified
4120 RYGB and 1457 SG low-risk cases defined by absence of previous
abdominal surgery, concomitant procedures, diabetes mellitus, sleep apnea,
cardiopathy, renal insufficiency, inflammatory bowel disease, immunosup-
pression, anticoagulation, BMI>50 kg/m2 and age>65 years. We chose
clinically relevant endpoints covering the intra- and postoperative course.
Complications were graded by severity using the comprehensive complication
index. Benchmark values were defined as the 75th percentile of the partici-
pating centers’ median values for respective quality indicators.
Results: Patients were mainly females (78%), aged 3811 years, with a
baseline BMI 40.8 5.8 kg/m2. Over 90 days, 7.2% of RYGB and 6.2% of SG
patients presented at least 1 complication and no patients died (mortality in
nonbenchmark cases: 0.06%). The most frequent reasons for readmission after
90-days following both procedures were symptomatic cholelithiasis and
abdominal pain of unknown origin. Benchmark values for both RYGB and
SG at 90-days postoperatively were 5.5% Clavien-Dindo grade IIIa compli-
cation rate, 5.5% readmission rate, and comprehensive complication index
33.73 in the subgroup of patients presenting at least 1 gradeII complication.
Conclusion: Benchmark cutoffs targeting perioperative outcomes in BS offer
a new tool in surgical quality-metrics and may be implemented in quality-
improvement cycle.
ClinicalTrials.gov Identifier NCT03440138
Keywords: bariatric surgery, benchmark, complication, morbidity, outcome
research, quality assessment, Roux-en-Y gastric bypass, sleeve gastrectomy
(Ann Surg 2019;270:859–867)
W ith growing complexity and cost of modern surgical practice,structured quality assessment became mandatory.1,2 Bench-
marking is among the most popular quality management tools in
companies’ process improvement cycles.3 Benchmarking is a mar-
ket-based learning method by which a company seeks to identify best
practices that produce superior results in other firms, and to enhance its
own competitive advantage by adopting them.4 In the surgical liter-
ature procedure-specific outcome benchmarks are largely lacking.5
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versity, Institute for Clinical and Experimental Medicine, Department of
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Recent studies in the field of visceral surgery established
benchmark cutoffs for best achievable patient-centered outcomes in
well-defined low-risk patient cohorts, allowing comparison among
centers and patient groups over time and between procedures.2,6–9
Bariatric surgery (BS) remains the most effective treatment for
severe obesity and associated diseases.10 The annual caseload of BS
worldwide has doubled during the past decade, and approached
700,000 operations in 2016.11 Together, the Roux-en-Y gastric
bypass (RYGB) and the sleeve gastrectomy (SG) constitute more
than 80% of bariatric procedures worldwide.11 Although frequently
performed, both procedures and follow-up care are not highly
standardized,12,13 posing a challenge in defining evidence-based
cutoffs for quality indicators for the peri- and postoperative course.14
Our aim was to identify the highest achievable quality (ie, the
global benchmarks) in BS, by assessing patient-centered outcome
indicators in low-risk patients who underwent SG or RYGB in high-
volume bariatric centers. The identified benchmarks are expected to
improve surgical quality by providing ‘‘goals’’ in postoperative




The establishment of benchmarks in BS followed a standard-
ized methodology, previously applied in visceral surgery.2,6–8,15 We
performed a multicentric retrospective cohort study based on pro-
spective institutional databases to define best achievable surgical
outcomes in primary laparoscopic RYGB and SG.
First, a large patient cohort from international expert centers
was gathered via personal invitation of distinguished surgeons.
Eligible centers had to meet the criteria listed in Table 1.16–33
The final collaborative consortium included 19 centers: 12 from
Europe (Arnhem, Basel, Brussels/Dendermonde, Bristol, Bruges,
Gothenburg, Madrid, Nice, Offenbach, Taunton, Wien, and Zurich),
3 from USA (Fresno, Providence, Weston), and 4 from South
America (Santiago de Chile, São Paulo [2 centers in each city]).
Second, to define the ‘‘benchmark bariatric patient,’’ evi-
dence-based criteria associated with a lower postoperative compli-
cation rate were applied (Table 1). Each center had to include all
consecutive benchmark cases with a documented follow-up of
minimum 90-days (including mortality), operated over a 5-year
period (June 1, 2012 to May 31, 2017).
Third, relevant outcome indicators for surgical quality were
assessed. To adjust for variability, median values of continuous
variables and the proportions of categorical variables were calculated
for each participating center. Benchmark cutoffs, indicating ‘‘best
achievable’’ result for each outcome indicator, were set at the 75th
percentile of the centers’ median values. Additionally, range and
median (ie, ‘‘premium result’’) of each indicator was computed.
The study protocol was preregistered on ClinicalTrials.gov
(NCT03440138). The approval of the Cantonal Ethics Committee
of Zurich, as well as of the ethical board of each respective center,
was obtained before data analysis.
Outcome Variables of Interest
Local investigators retrieved patient-specific data and uploaded
themtoa secureand anonymizedonline data-entrymanagement system
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TABLE 1. Criteria Used to Identify Participating Centers and ‘‘Benchmark’’ Cases
Center Inclusion Criteria Patient Inclusion Criteria Patient Exclusion Criteria
Annual caseload  200 bariatric cases, at least
during the last year of the study period19,20
Age 18–65 yrs21–23 Previous intra-abdominal surgery (including previous
bariatric surgery)24,25
Minimum 30 benchmark cases over the 5-yr
study period for inclusion in the procedure-
specific (RYGB or SG) establishment of
global benchmarks
Low risk profile (please read ‘‘exclusion
criteria’’)
Cardiovascular disease (eg, cardiac arrhythmia, stroke,
coronary artery disease)22
Available prospective bariatric database Preoperative BMI  50 kg/m2 26,27 History of thromboembolic events and/or therapeutic
anticoagulation27
Interest in bariatric outcomes, documented
by 1 publication(s) on bariatric surgery
Laparoscopic primary Roux-en-Y gastric
bypass or sleeve gastrectomy24
Diabetes mellitus (Type 1 and Type 2, as defined by the
American Diabetes Association)28,29
‘‘Clinical excellence’’ or national reference
centers18
Documented follow-up of at least 90 d30 Obstructive sleep apnea (recurrent episodes of upper
airway collapse during sleep)26,27
American Society of Anesthesiologists
(ASA) score < IV31
Chronic obstructive pulmonary disease (FEV1/
FVC<0.7)24
Chronic kidney disease (eGFR <30 mL/min/1.72 m2)22
Inflammatory bowel disease (ulcerative colitis, Crohn
disease)32
Immunosuppression therapy (ie,. steroids, calcineurin
inhibitors, etc.)33,34
Associated surgical procedures (ie,. cholecystectomy,
hiatoplasty, liver biopsy)17
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provided by the University Hospital Zurich.34 Data were audited and
checked for completeness by DG and included baseline characteristics
of patients (age, sex, body-mass index [BMI], comorbidities), operation
characteristics, inpatient complications by severity according to the
Clavien–Dindo (CD) grading system,35,36 length of stay, readmissions
(time from operation, reason, and treatment), last follow-up, and yearly
postoperative BMI. To enable the assessment of cumulative morbidity
over time, the Comprehensive Complication Index (CCI) was used.37
The CCI expressesmorbidity on a continuous numeric scale from 0 (no
complications) to 100 (death) by weighing all postoperative compli-
cations according to the CD classification. Relevant bariatric compli-
cations, such as staple line/anastomotic leak, anastomotic orgastric tube
stenosis, internal hernia, marginal ulcer at the gastrojejunostomy, were
additionally analyzed.16,38,39 Postoperative weight loss was expressed
as %total weight loss, and excess body mass index loss (EBMIL) (%
excess BMI loss, with BMI ¼ 25 kg/m2 considered as normal).40
Benchmark cutoffs for overall inpatient costs were calculated sepa-
rately for patients with or without any surgical complications by using
the algorithm developed by Staiger et al.41
Proof of Concept
To validate the need for outcome benchmarks in BS, we
applied 3 complementary measures. First, we collected data on
90-day mortality of all RYGB and SG cases operated during the
study period. Second, we selected 1 participating center (Number 2
in Fig. 1) to provide outcome data of all nonbenchmark RYGB cases.
Third, we identified previously published studies by the participating
centers reporting 30-day major complications rates in consecutive
and secondary RYGB cohorts to objectify the additional burden of
‘‘high-risk’’ cases on the early postoperative morbidity.
Statistical Analysis
Centers that contributed with <30 cases per type of BS
(RYGB or SG) were excluded from analyses in the respective
operation subgroup.42 Discrete variables were described using
count (percent), and continuous variables were described using
medians (with interquartile range). Kaplan–Meier curve was
used to describe the occurrence of postoperative CD >II
complications over observation time. Statistical analysis was
performed using the R software 3.5.1 (R Foundation, Vienna,
Austria).
RESULTS
Out of all 39,424 consecutive elective BS cases (RYGB,
SG, bilio-pancreatic diversion, gastric banding, single anasto-
mosis gastric bypass, single anastomosis duodenoileal bypass,
gastric plication) performed over 5 years in the 19 included
centers, 4120 RYGB and 1457 SG benchmark cases were iden-
tified (Supplementary Figure 1, http://links.lww.com/SLA/
B717). The proportion of benchmark cases within the case
mix of participating centers varied from 4% to 69% (Fig. 1).
Baseline characteristics of patients and procedures are presented
in Supplementary Table 1, http://links.lww.com/SLA/B717.
Majority of centers had a >90% uneventful postoperative course
rate during the first 90-days for both procedures (Supplementary
Figure 2, http://links.lww.com/SLA/B717). The cumulative haz-
ard of CD grade >II events after BS was below 4% at 90 d
(Fig. 2); nevertheless, it increased constantly over time during
the first 2 postoperative years (Supplementary Figure 3, http://
links.lww.com/SLA/B717). The most common reasons for read-
missions until last follow-up are shown in Figure 3 and Supple-
mentary Table 2, http://links.lww.com/SLA/B717. There was a
great between-center variability in the size of benchmark
cohorts, in median length of follow-up, and in the cumulative
hazard of reinterventions beyond 90 days (Supplementary
Figure 4, http://links.lww.com/SLA/B717). Centers with higher
caseload showed a trend toward achieving lower mean CCI over
90 days; however, these correlations were not statistically
FIGURE 1. Casemix of elective bariatric surgery (BS) in participating centers over the 5-yr inclusion period (June 2012–May 2017).
Percentages show the proportion of benchmark Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) cases within the total
elective BS caseload.
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FIGURE 2. Cumulative hazard of Clavien–Dindo grade> II events in benchmark patients during the first 90-d after bariatric surgery
























































FIGURE 3. Cumulative incidence (%) of the most common reasons for readmission in benchmark patients after bariatric surgery.
A, Roux-en-Y gastric bypass (n ¼ 4120, median follow-up ¼ 1.9 yr, [range: 0.25–6 yrs]). B, Sleeve gastrectomy (n ¼ 1457, median
follow-up ¼ 1.6 yr, [range: 0.25–6 yrs]). GERD indicates gastro-esophageal reflux disease.
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significant (Supplementary Figure 5, http://links.lww.com/SLA/
B717).
Benchmark Cutoffs of Quality Indicators
Outcome benchmarks of RYGB and SG are shown in Tables 2
and 3, with additional data including range and median in Supple-
mentary Table 3, http://links.lww.com/SLA/B717.
Roux-en-Y Gastric Bypass
At baseline, the cohort’s mean age was 38.2 11.1 years with
a BMI of 41.3 6.2 kg/m2. Before discharge, 3.4% of patients
presented at least 1 complication. Readmissions due to grade >II
events occurred in 2.5%, 4.1%, 5.5%, and 9.4% of cases at postop-
erative days 30, 90, 180, and 365. Ninety-day and 1-year mortality
were 0% and 0.02% (1 patient died from a cardiovascular event on
TABLE 2. Benchmark Cutoffs for Roux-en-Y Gastric Bypass (75th Percentile of Centers’ Median)
1. Perioperative Course
Operation duration 2 h
Conversion to open surgery 0%
Intraoperative blood transfusions 0%
Postoperative blood transfusions 2%
Postoperative ICU admission 0.14%
ICU stay in patients admitted to ICU 1 d
Hospital stay 4 d
Hospital cost in CH or USA/in the EU 16,203 CHF or USD / 5402 EUR
Hospital cost in patients with complications in CH or USA / in the EU 26,485 CHF or USD / 8705 EUR
2. Morbidity and Mortality Until Discharge Until 30-d Until 90-d
Uneventful postoperative course >94% >91% >90%
Readmission — 4% 5.5%
Reoperation 2% 2.5% 4%
Any complication 6% 9% 10%
Complication grade  IIIa 3.5% 5% 5.5%
Mortality 0% 0% 0%
CCI In patients with at least 1 Clavien–Dindo Grade II complication 26.2 32.5 33.73
Signature complications
Anastomotic leak 0% 1.1% 1.3%
Stenosis of the anastomosis 0% 0.3% 1.2%
Postoperative bleeding 2.2% 2.2% 2.2%
Small bowel obstruction/internal hernia 1.4% 2.1% 2.1%
Wound infection 0.5% 0.5% 0.5%
Marginal ulcer 0% 0.3% 1.5%
TABLE 3. Benchmark Cutoffs for Sleeve Gastrectomy (75th Percentile of Centers’ Median)
1. Perioperative Course
Operation duration 1.5 h
Conversion to open surgery 0%
Intraoperative blood transfusions 0%
Postoperative blood transfusions 1.3%
Postoperative ICU admission 0%
ICU stay in patients admitted to ICU 4 d
Hospital stay 3 d
Hospital cost in CH or USA/in the EU 16,204 CHF or USD / 5402 EUR
Hospital cost in patients with complications in CH or USA / in the EU 25,949 CHF or USD / 8650 EUR
2. Morbidity and Mortality Until Discharge Until 30-d Until 90-d
Uneventful postoperative course >92% >89% >88%
Readmission — 4% 5.5%
Reoperation 2% 2% 3%
Any complication 8% 11% 12%
Complication grade  IIIa 2.5% 5% 5.5%
Mortality 0% 0% 0%
CCI In patients with at least 1 Clavien–Dindo Grade II complication 26.22 32.53 33.73
Signature complications
Staple line leak 0% 0.15% 0.15%
Dysphagia/Stenosis of the gastric tube 0% 0.14% 0.27%
Postoperative bleeding 1.7% 1.7% 1.7%
Small bowel obstruction 0% 0% 0%
Wound infection 0% 0% 0%
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postoperative-day 211). At 1-year (follow-up: 82.5%), the cohort’s
mean BMI was 27.7 4 kg/m2, EBMIL: 86.8 25.5% and %weight
loss: 32.7 8.3%.
Sleeve Gastrectomy
At baseline, the cohort’s mean age was 37.0 10.8 years with
a BMI of 38.9 5.2 kg/m2. Before discharge, 3.6% of patients
presented at least 1 complication. Readmissions due to grade >II
events occurred in 2.5%, 3.1%, 3.7%, and 5.9% of cases at postop-
erative days 30, 90, 180, and 365. One-year mortality was zero. At 1-
year (follow-up: 68.2%), the cohort’s mean BMI was 28 4.9 kg/m2,
EBMIL: 84.3 37.6% and %weight loss: 27.5 10.2%.
Proof of Concept
The 90-day mortality rate in the nonbenchmark cases was
0.05% (11/21,830) after RYGB and 0.09% (8/8813) after SG. The
90-day postoperative outcomes of nonbenchmark RYGB patients
operated at Center Number 2 (n ¼ 468) are compared with the
benchmark cutoffs for the same quality indicators in Supplementary
Table 4, http://links.lww.com/SLA/B717.A literature search identified
10 publications covering 3993 RYGB cases operated at the participat-
ing centers (SupplementaryTable 5, http://links.lww.com/SLA/B717),
with a median 30-day major complication rate of 10.75%.
DISCUSSION
This multicenter study established outcome benchmarks for
the 2 most frequently performed bariatric procedures by applying a
recently developed standardized methodology.2 In the current report
of low-risk BS patients operated in 1 of 19 high-volume referral
centers located on 3 continents, main findings were a zero 90-day
mortality rate, a low early postoperative morbidity rate with the
majority of reinterventions occurring after the first 90-days. The
cohort’s 1-year percentage weight loss was comparable to the mean
procedure-specific pooled outcomes published in the 2018 IFSO
global registry report.43
Identified outcome benchmarks may serve as a reference for
bariatric centers to compare their ownoutcomes in similarly low risk or
even all bariatric patients and to take action when eventual perfor-
mancegaps are identified. So far, these attemptswere impededbygreat
variability in case mix between centers.17,43,44 The approach is remi-
niscent to the concept of propensity scoring study participants, where
randomization at baseline is mimicked by cohorts that are comparable
on main measured covariates.45 In practice, random allocation of
patients to different bariatric centers is not feasible; therefore, the
concept of establishing global benchmarks based on multicentric data
of low-risk patients seems to be an appealing alternative to allow
comparison of outcomes and thus, of surgical quality.
This study aimed to represent the ‘‘real world’’ by including
European, Northern and Southern American centers led by recog-
nized experts in the field of BS. All centers had sufficient caseload, a
prospective bariatric database and previous publication(s) on surgical
outcomes. The selection of benchmark patients was performed by a
strict and stepwise risk stratification aiming to identify the ‘‘healthi-
est’’ BS candidates with the least expected complications. Each
submitted case was read by one of the principal investigators in
Zurich, and clarification was requested from the coinvestigators in
case of incompletely submitted case report forms. Our protocol
focused on CD >II events, given that medically treated complica-
tions of BS are frequently managed by nonsurgeon healthcare
providers outside of bariatric centers and thus, do not obviously
appear in institutional databases.46
All included patients were operated in academic centers with
teaching assignments, and consequently, with potentially increased
operation duration.47 This may explain why established outcome
benchmarks for operation times in our study were not shorter, but in a
similar range as those reported for all laparoscopic RYGB and SG
(including high-risk patients and redo surgery) performed in the USA
in 2015 to 2016.45
Length of stay is not a pure quality indicator, since it highly
depends on health care systems and at some extent, on the attitude of
patients. We are witnessing a trend toward shorter inpatient stays
following BS. The safety of early discharge on the first postoperative
day in a selective group of bariatric patients without significant
comorbidities is supported by the 2015 dataset of the MBSAQIP.48
Furthermore, SG in selected low-risk patients has been recently
found to be safely feasible even as an outpatient procedure.49
Therefore, it is of no surprise that the 2018 IFSO global registry
report showed shorter lengths of stay for RYGB (2 vs 4 d) and a
similar one for SG (3 d) in comparison with the benchmarks
identified in the current study, which were derived from a cohort
operated between 2012–2017.43
The study revealed an interesting pattern in postoperative
morbidity, as most reoperations and reinterventions occurred beyond
90 days. This is in line with postbariatric readmission rates observed
in The Danish National Health Surveys,50 but it is in contrast to
previous reports on the temporal occurrence of reinterventions after
other types of major abdominal surgeries (ie, hepatectomy, esoph-
agectomy), where the vast majority of CD grade >II events were
recorded within 30 days.6,7 Several explanations to this finding may
be possible. First, both BS patients and bariatric centers are com-
mitted to perform a lifelong follow-up, which may not be the case for
other types of surgeries. Second, severe obesity is a chronic disease,
which is often characterized by cyclic episodes of weight loss and
weight regain, as well as a higher risk for the development of a series
of associated conditions that may require surgical care (ie, gallstone
disease, GERD).51 In this study, symptomatic cholelithiasis, GERD,
and weight regain were among the most frequent reasons of long-
term postbariatric readmissions, although the prevalence of these
pathologies may not entirely depend on surgical performance at the
index procedure, and increases with length of follow-up. Abdominal
pain of unknown origin was the most common reason of readmission
after RYGB and the second most frequent one after SG. This is
somewhat surprising and may be in part related to the retrospective
design of the study. Surgical databases often record the chief
complaint of the patients’ at presentation and are not always updated
by the definitive diagnosis retained at the end of the often time-
consuming work-up.
The concept of establishing benchmarks in BS was validated
by complementary approaches. First, we found that compared with
the zero 90-day mortality of benchmark patients, the same centers
recorded a 0.06% mortality rate following RYGB and SG in non-
benchmark cases. This small difference emphasizes the need for
quality indicators focusing on postoperative morbidity. Second, we
found that in 1 participating center the overall morbidity in the
nonbenchmark cases was above the global benchmark cutoff, mainly
due to the higher frequency of CD IIIb complications. Third, the
previous outcome reports on consecutive or secondary RYGB pub-
lished by the participating centers showed a higher 30-day major
complication rate than the benchmark cutoff (10.75% vs 5%),
highlighting the additional burden of postoperative morbidity
observed in ‘‘high-risk’’ cases.
This study has some inherent limitations. First, the quality of
current institutional surgical databases seems to be suboptimal for
capturing the full spectrum of postoperative morbidity, especially
beyond 90 days. This could be improved in the future by external
auditing of surgical databases and by replacing self-reporting with
automatized data input methods. Ibrahim et al17 also found a wide
variation in postoperative severe complications rates among
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accredited BS centers in the USA. In the current study, it was not
possible to judge whether between-center differences reflected vari-
ability in surgical performance or were due to missing data regarding
postoperative events. Although benchmark cutoffs were established
until 90-days postoperatively in patients with 100% follow-up, we
cannot exclude that some complications may have been underre-
ported. Second, to minimize the confounding effect of a potentially
hostile intra-abdominal status and of associated procedures on
postoperative morbidity, we excluded cases with previous abdominal
surgery and with additional nonbariatric procedures performed in
combination with the index procedure, including cholecystectomies.
This may at least partly explain why symptomatic cholelithiasis
ranked among the most frequent postbariatric reasons for readmis-
sion.51 Third, the current methodology of global surgical benchmark
establishment is bounded by logistic obstacles, leading to a consid-
erable burden for its future reproductions. The rapid evolution of
surgical and endoscopic bariatric procedures, as well as the increas-
ing caseload and experience of referral centers will mandate the
regular update of bariatric benchmarks. Ultimately, this process
needs to be automatized by development and adaptation of BS
registries. Fourth, the case mix in the presented study does not
reflect current practices: SG, the dominant operation worldwide,11
represented only 26% of benchmark cases, thus future studies should
aim to update benchmarks for SG with the inclusion of centers with a
higher experience with this technique.
In conclusion, we consider this project as an inaugural study
introducing the concept of benchmarking in BS. The surgical com-
munity’s genuine desire to improve patients’ postoperative outcomes
has a crucial role in increasing penetrance of BS and in decreasing
complication-related patient discomfort and healthcare expenditures.
The concept of benchmarking is expected to be embedded in surgical
quality improvement cycles, and to stimulate the need for compre-
hensive large databases allowing precise and timely identification of
both global benchmarks and institutional outcomes.
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DISCUSSANTS
Nicolò de Manzini (Trieste, Italy):
This study is well structured using an original method based
on economic models. The idea of finding some outcome benchmarks
for ‘‘easy’’ cases of bariatric surgery, in absence of international
recognized data, could certainly be useful in future comparisons.
However, the benchmark group represents only 14.1% of the
whole population, with a larger number of cases coming from smaller
centers; this could be explained by the stronger selection criteria used
in smaller centers and could represent a potential bias. The interest-
ing result is that most postoperative complications appear beyond 90
days, which differs greatly frommajor abdominal surgery, and again,
demonstrates many reasons why the follow-up period for bariatric
patients should be longer.
It is clearly demonstrated that the expected outcomes in
patients without the described exclusion criteria should be good in
at least 95% of cases.
The main question that arises is: what should the outcome
benchmark be in patients with comorbidities that are currently often
found in bariatric patients? Such an analysis could have been
more useful to understand which patients were suitable for centrali-
zation. Based on the current study, it would appear that easy and
uncomplicated patients could be operated on in a mid-volume center
as well.
In summary, this important data collection and robust statisti-
cal analysis could have focused on a more complicated group of
patients, which may better represent the ‘‘real world’’ that the authors
cited at the beginning of the discussion.
Response From Marco Bueter (Zurich, Switzerland):
Thank you very much for the encouraging comments and
underlining our finding on the temporal distribution of postbariatric
complications. Indeed, our data highlight the fact that bariatric
surgery requires a long-term follow-up, since the rate of reoperations
and reinterventions did not reach a plateau by the end of the second
postoperative year. We agree that similar studies are needed to
identify the best achievable outcomes in higher risk patients as well.
Our plan is to perform such studies in the future, with a special focus
on the best achievable outcomes in revisional bariatric surgery.
However, as a pioneering step to introduce the concept of bench-
marking in bariatric surgery, we aimed to identify the best achievable
outcomes in a homogenous cohort of low-risk patients. The hypoth-
esis was that the best procedure-specific outcomes could be achieved
when low-risk patients are operated on in high-volume centers by
experienced surgeons. This methodology was summarized by Staiger
et al in the British Journal of Surgery earlier this year, and has been
previously applied in other fields of visceral surgery. Although the
study population represented only 14% of the total bariatric caseload,
the 5577 identified benchmark cases provided a meaningful cohort
for the purpose of this study. Given the various possible applications
of the identified benchmark cut-offs (ie, the unbiased comparison
of different centers by accounting for differences in case-mix, the
identification of ‘‘out of benchmark’’ cases to be presented at morbid-
ity-mortality meetings, the validation of the introduction of a new
procedure, the identification of cases suitable for the teaching of
surgical trainees, etc.) we consider our study relevant for the improve-
ment of clinical practice and stimulation of similar initiatives.
Mario Morino (Torino, Italy):
Thank you for this interesting paper and concept of bench-
marking. This is quite a complex concept for surgeons. Don’t you
think that this concept and these results, based only on 14% of the
population, might have a devastating medico-legal impact? Could
you please comment on this point.
Response From Marco Bueter (Zurich, Switzerland):
Thank you for your important question. The quality control of
surgical performance is getting more and more meticulous each year.
Since the surgeons are at the forefront of detecting and managing
postoperative complications, I believe that quality improvement
initiatives should be led by the surgical community, instead of
politicians, health insurance companies or other policymakers.
The decision to set benchmark cut-offs at the 75th percentile of
the participating centers’ median outcomes supports the aim of
providing achievable goals. The establishment of surgical bench-
marks will need to be updated at a regular interval, reflecting the
current best practices. Overall, I do not expect devastating medico-
legal consequences; on the contrary, I foresee that our study will
inspire quality improvement initiatives.
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Bas Wijnhoven (Rotterdam, The Netherlands):
Thank you for your presentation. If you combine data from
many centers, you need to have agreed definitions for complications.
We need to be sure of the validity of the databases that you used, to
make sure no complications are left out. So, how did you establish
this, and what was your plan to make sure that all of the data entered
were of good quality? Did you check them?
Response From Marco Bueter (Zurich, Switzerland):
Thank you very much for your comment. First, before we
started collecting the data, we preregistered our study protocol at
ClinicalTrials.gov to define endpoints of interest in a transparent
fashion. Second, criteria for the participation of the centers included
a prospective institutional bariatric database and at least 1 previous
publication on surgical outcomes, to guarantee the sufficient quality
of available data. Third, the complications were graded according to
severity by using the Clavien–Dindo classification, which was
emailed to every coauthor as soon as they confirmed their willingness
to participate in the study. Fourth, each submitted case was controlled
for completeness by the first author of the study. If an incomplete
case submission was detected, the coauthors were recontacted and
asked to provide additional information. Overall, in a retrospective
study it is challenging to achieve complete data collection. Never-
theless, we tried to create conditions that minimize the risk
of underreporting.
Norbert Senninger (Münster, Germany):
I would like to join the other speakers in applauding your
study. My comment or question concerns your exclusion of patients
with a BMI of above 50. We know that the sleeve gastrectomy is
especially valuable in patients with a BMI above 50, for which other
procedures do not work. Could you please comment on the data
that relates to patients who are considered to be ‘‘super obese’’?
Also, please make sure that the modern techniques of dealing with
leakages are available at all of the centers. I’m mainly addressing the
endo-vacuum approach, which is not of very widespread use in
bariatric surgery, even though it can save lives.
Response From Marco Bueter (Zurich, Switzerland):
Thank you verymuch for your comment and applause, which I
highly appreciate. The reason we considered patients with a BMI
>50 kg/m2 as nonbenchmark cases was based on previous cohort
studies (Flum et al N Engl J Med 2009), showing that the risk of
perioperative complications is increased in the ‘‘super obese.’’
With regards to your second question, all included centers
were high-volume academic bariatric referral centers, which were
supposedly equipped with state-of-the art technology and disposed of
dedicated multidisciplinary teams to detect and treat postoperative
complications.
John Reynolds (Dublin, Ireland):
Congratulations on your paper. I just have a brief question.
When you introduced your topic, you talked about complex oper-
ations and how they have been benchmarked. However, you based
your population on the easiest cases, whereas there is a great need to
benchmark the more complex metabolic surgical cases or bariatric
surgery for end-stage renal surgery, for example. I’m just wondering
whether you’re researching this. Why did you choose the easiest
cases over the more complex ones? Most benchmarking, with all of
its implications, has been based on complex cases.
Response From Marco Bueter (Zurich, Switzerland):
Thank you very much for your question. This concern has
been covered in part by my answer to the first discussant. When
introducing a new methodology in a field, it seems intuitive to follow
a previously validated approach, that is, to establish benchmark cut-
offs in low-risk cases, to demonstrate best achievable outcomes in a
given field. As a next step, future studies will need to focus on higher
risk cases and complex clinical scenarios, in addition to the best
achievable metabolic outcomes.
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